VaxDesign, is a privately held U.S. biotechnology company, based in Orlando, Florida, that develops, manufactures, and markets in vitro models of the human immune system. Its Modular IMmune In vitro Construct (MIMIC®) technology melds immunology with engineering to find elegant solutions to complex biological problems. The MIMIC® system was initially developed for the Rapid Vaccine Assessment Program of the U.S. Defense Advanced Research Projects Agency (DARPA) and has since been funded by several other U.S. federal agencies, such as the Defense Threat Reduction Agency, Biomedical Advanced Research and Development Authority, Army Chemical Biological Medical Systems (CBMS), and National Institute of Standards and Technology (NIST).

Publications 26 show all

  • 5
    Dendritic Cells/immunology
  • 3
    Antibodies, Viral/immunology
  • 3
    Models, Immunological
  • 2
    CD4-Positive T-Lymphocytes/immunology
  • 2
    Influenza Vaccines/immunology
  • 2
    Titanium/immunology
  • 1
    Adaptive Immunity/immunology
  • 1
    Adjuvants, Immunologic
  • 1
    Adjuvants, Immunologic/pharmacology
  • 1
    Animal Testing Alternatives

Patents 152show all

  • 88
    C12N - Microorganisms or enzymes
  • 81
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 28
    A61K - Preparations for medical, dental, or toilet purposes
  • 19
    C12M - Apparatus for enzymology or microbiology
  • 17
    C07K - Peptides
  • 8
    B01L - Chemical or physical laboratory apparatus for general use
  • 7
    Y02A - Technologies for adaptation to climate change
  • 5
    A01K - Animal husbandry
  • 4
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 1
    B29C - Shaping or joining of plastics

Contact Information

12612 Challenger Parkway Suite 365
Orlando, FL 32826
United States

Overview

Total FundingEmployeesLast Funding DateStatus
1-10Acquired